https://www.avient.com/sites/default/files/2019-12/Fermium_IR_Deck_12.16.19_for_Website.pdf
Both parts are made of silica/glass or
polymer
4.
Binder
• PET, Polyester, Kevlar yarns coated with Swellcoat
(absorbs and blocks water)
2 3 4
5
7
6
8
9.
Cable jacket/sheath– Made of
PE
9
Fiber-Line Product
PolyOne Materials
F I B E R O P T I C A L G R O W T H D R I V E R S
PolyOne Corporation 20
5G Networks
Enable lower latency, greater
flexibility & efficiency
Installation of these networks are
in the very early stages
Installation will start in urban
hubs and will continue to expand
into suburban and rural areas
By 2025, only 14% of the world
will have 5G connections
Growth is expected over multi-
year period
5G technology will be a leading growth driver in fiber optic cable for several years
10x
Speed Increase
&
8x
More Antennae Required
5G vs. 4G
PolyOne Corporation 21
Safety Technology Geography Service FinancialPeople
Low EH&S
risk profile
New and
complementary
technologies
Leverage our
global footprint
Strong
customer
relationships
Foundational
operating
margins of
8-10% with
ability to double
Motivated team
with a specialty
culture
I N V E S T - T O - G R O W M & A S T R A T E G Y
PolyOne Corporation 22
Capture
sourcing
synergies
Cross-sell
& blend
technology
8-10%
operating
margins
I N V E S T - T O - G R O W M & A P L A Y B O O K
Protect
customers
Retain
employees
Implement LSS to
drive efficiency
improvements
Innovate with
combined
portfolio
Safety
First!
https://www.avient.com/sites/default/files/2025-03/Q4 2024 Avient Webcast Slides w Non-GAAP.pdf
All Rights Reserved
2025 4
Full-year 2024 organic revenue growth - by region
▲5% ▲1% ▲5% ▲15%
Year-over-year revenue growth, excludes the impact of foreign exchange
US & Canada Europe, Middle
East & Africa
Asia Latin America
5Copyright © .
All Rights Reserved
2025 17
ADJ.
EPS - Full year 2025
$2.70 to $2.94
Q1 2025
$0.76
adj.
https://www.avient.com/sites/default/files/2025-02/News Release - AVNT-2024.12.31-News Release 2.12.25 2PM_0.pdf
Microsoft Word - Avient Announces Fourth Quarter and Full Year 2024 Results
1
NEWS RELEASE
FOR IMMEDIATE RELEASE
Avient Announces Fourth Quarter and Full Year 2024 Results
• Fourth quarter sales increased 4% to $747 million and full year sales increased 3% to
$3,240 million
• Organic sales, which excludes the impact of foreign exchange, grew 5% and 4% in the
fourth quarter and full year, respectively, driven by positive growth in all regions
• Fourth quarter and full year GAAP EPS from continuing operations of $0.52 and $1.84
compared to $0.30 and $0.83 in the prior year
• Fourth quarter adjusted EPS of $0.49, above mid-point of guidance range of $0.46 to
$0.50 and includes a $0.01 unfavorable impact from foreign exchange
• 2024 full year adjusted EPS of $2.66 represents an increase of 13% over the prior year,
driven by sales growth and margin expansion in both segments
• 2025 full year adjusted EPS expected to range from $2.70 to $2.94; the mid-point
represents 11% growth when excluding the unfavorable impact of foreign exchange of
$0.12
CLEVELAND – February 13, 2025 – Avient Corporation (NYSE: AVNT), an innovator of
materials solutions, today announced its fourth quarter and full year results for 2024.
As we begin 2025, we are
poised to execute our strategy to deliver value for our shareholders by prioritizing our portfolio,
amplifying innovation, leveraging digital technologies and harnessing the collective strengths of
our more than 9,000 global employees.”
Eastern Time on February 13,
2025.
https://www.avient.com/news/archives?page=9
April 4, 2024
May 14, 2025
May 06, 2025
https://www.avient.com/sites/default/files/2021-09/mevopur-colors-for-ophthalmic-closures-application-bulletin-cn.pdf
MEVOPUR Colors for Ophthalmic Closures Application Bulletin_CN8.18-1
* 可根据要求提供FDA/EU合规信息
应用公告
用于眼科药物容器盖的
着色剂MEVOPUR™
用于眼部(眼科)用药物容器盖的MEVOPUR标
准母粒系列产品符合美国眼科学会(AAO)的颜
色标准。
法规支持
经过预测试的原材料:
- ISO 10993-1
- USP 第、章(VI类)
- USP (指南),6.2.3 可萃取元素;
USP
- ICHQ3D/USP 2 可萃取金属
- 欧洲药典 3.1 聚烯烃(如适用)
FDA发布的注册药品管理档案(III类)和/或医
疗器械管理档案
食品接触符合FDA/EU*要求
•
•
•
主要特性
在三个通过ISO 13485认证的医疗生产线生产
全球统一的配方,提供全球一致性和供应链保
障
变更控制记录的不限于CAS编号级别,降低变
更风险
不含动物源性物质和邻苯二甲酸盐
标准母粒在PE载体中提供,可根据要求在PP
中提供
可以采用针对应用选择的特定树脂提供预着色
配方
•
•
•
•
•
药物类型 颜色说明 潘通色号参考 埃万特产品代码(PE基)
肾上腺素能激动剂组合 浅绿色 373 C PE6M176349
肾上腺素能激动剂 紫色 2583 C PE4M176057
抗感染药 棕褐色 467 C PE8M176130
非甾体类抗炎药 灰色 冷灰色 4 C PE7M176184
甾体类抗炎药 粉色 197 C PE3M176237
免疫调节剂类抗炎药 橄榄绿 5763 C 按要求提供
β-受体阻滞剂 黄色 黄色 C PE1M176160
β-受体阻滞剂组合 深蓝色 281 C PE5M176272
碳酸酐酶抑制剂 橘黄色 1585 C PE2M176089
细胞毒素 黑色 6 C PL9M176008
缩瞳剂 深绿色 348 C PE6M176267
散瞳剂和睫状肌麻痹剂 红色 1797 C PE3M176236
前列腺素类似物 绿松石 326 C PE5M176273
适用医疗保健使用限制—见下文。
在不限制本声明的一般性的情况下,不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用:
(1) 接触人体组织或体液长达30天或更长时间;
(2)“整形”(整容或重建)手术;
(3) 生殖植入物或任何节育器械;或者
(4) 用于支持或维持人类生命的永久性(超过30天)植入式医疗器械中的任何关键组件。
https://www.avient.com/news/avient-s-malm-sweden-site-earns-iscc-plus-certification-mevopur-healthcare-bio-based-polymer-solutions
April 4, 2024
May 06, 2025
Apr 03, 2025
https://www.avient.com/sites/default/files/resources/September%2520Investor%2520Presentation.pdf
Both parts are made of silica/glass or
polymer
4.
Binder
• PET, Polyester, Kevlar yarns coated with Swellcoat
(absorbs and blocks water)
2 3 4
5
7
6
8
9.
Cable jacket/sheath– Made of
PE or PVC
9
Fiber-Line Product
PolyOne Materials
F I B E R O P T I C A L G R O W T H D R I V E R S
PolyOne Corporation 22
5G Networks
Enable lower latency, greater
flexibility & efficiency
Installation of these networks are
in the very early stages
Installation will start in urban
hubs and will continue to expand
into suburban and rural areas
By 2025, only 14% of the world
will have 5G connections
Growth is expected over multi-
year period
5G technology will be a leading growth driver in fiber optic cable for several years
10x
Speed Increase
&
8x
More Antennae Required
5G vs. 4G
PolyOne Corporation 23
Safety Technology Geography Service FinancialPeople
Low EH&S
risk profile
New and
complementary
technologies
Leverage our
global footprint
Strong
customer
relationships
Foundational
operating
margins of
8-10% with
ability to double
Motivated team
with a specialty
culture
I N V E S T - T O - G R O W M & A S T R A T E G Y
PolyOne Corporation 24
Capture
sourcing
synergies
Cross-sell
& blend
technology
8-10%
operating
margins
I N V E S T - T O - G R O W M & A P L A Y B O O K
Protect
customers
Retain
employees
Implement LSS to
drive efficiency
improvements
Innovate with
combined
portfolio
Safety
First!
https://www.avient.com/idea-center/idea-center?all=true
More
Understanding PCR in Closure Applications
Understanding the challenges of incorporating PCR and exploring potential solutions.
More
Amped-Up Off-Road Performance
Boost the off road experience with advanced polymer materials that deliver innovation.
More
Beverage Closure TPE Innovation
XO Slider from XOLUTION raises performance without disrupting established processes.
https://www.avient.com/news/click-here-new-cosmetics-microsite-featuring-gsdi-colorsperse-silicone-colorants-focuses-innovative-formulators
August 4, 2014
May 14, 2025
May 14, 2025
https://www.avient.com/sites/default/files/2025-03/380605_AVIENT_2024AR_full_250325.pdf
As we embark on 2025, I do so with optimism and energy
for our company and the stakeholders we serve.
Eastern
Time on Wednesday, May 14, 2025.
Environmental, Health and Safety 4.